Loading company…
Tokaido Health develops AI software to help patients access lower-cost medication options.
Tokaido Health offers an AI medication platform for infusion site-of-care guidance, biosimilar substitution, formulary optimization, and medication reconciliation. Founded in 2025, the company is based in San Mateo, US, and serves healthcare providers, payers, and other organizations. On May 15, 2026, it raised USD 25.00 mn from Norwest, Primary Venture Partners, Next Ventures, and Scrub Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in